The Valley Desk

NCT05735184 · Interventional trial

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Overall registry status Recruiting

Phase 1

Conditions AML With Mutated NPM1, Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Acute Myeloid Leukemia, in Relapse, KMT2Ar, Mixed Lineage Leukemia Gene Mutation, Myeloid Sarcoma, NPM1 Mutation, Nucleophosmin 1-mutated Acute Myeloid Leukemia, Refractory AML

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov